TITLE:
      Study Comparing Liquid and Tablet Buprenorphine Formulations - 5
SUMMARY:
      The purpose of this study is to compare liquid and tablet buprenorphine formulations.
DETAILED DESCRIPTION:
      Participants were inducted on either liquid or tablet buprenorphine, in a double-blind,
      double-dummy manner. They each reached a steady state by the second week, and were scheduled
      to have blood draws in weeks 3, 4, 7, 8, 11, 12, 15, and 16.
ELIGIBILITY CRITERIA:
      Inclusion Criteria:

        M/F ages 21-50. Opiate dependence according to DSM-IV criteria. Currently enrolled in the
        outpatient protocol comparing liquid and tablet formulations of Buprenorphine. Agreeable
        to conditions of study and signed informed consent.

        Exclusion Criteria:

        Psychiatric disorder that requires medication therapy. History of seizures. Pregnant
        and/or nursing women. Dependence on ETOH or benzodiazepines or other sedative-hypnotics.
        Acute hepatitis. Other medical conditions that deem participation to be unsafe.
